Keyphrases
Opioid Growth Factor
100%
Naltrexone
66%
Enkephalin
58%
Opioid Growth Factor Receptor (OGFr)
48%
Opioid Receptors
35%
Opioid Antagonist
28%
Cell Proliferation
25%
DNA Synthesis
21%
Methadone
18%
Endogenous Opioids
18%
Opioids
15%
Ocular Surface
12%
Experimental Autoimmune Encephalomyelitis
12%
Low-dose Naltrexone
12%
Endogenous Opioid System
11%
Multiple Sclerosis
11%
Diabetic Rats
11%
Receptor Blockade
10%
Naloxone
10%
Lactation
10%
Labeling Index
10%
Head-and-neck
10%
Re-epithelialization
9%
Human Pancreatic Cancer
9%
Opioid Peptides
9%
Tumor
9%
Cerebellum
9%
Squamous Cell Carcinoma of Head
9%
Nude Mice
7%
Corneal Epithelium
7%
Cornea
7%
Neuroblastoma
7%
Brain Development
7%
Developing Rat
7%
Adult Rats
7%
Growth Factors
7%
Tissue Culture
7%
Young Rats
7%
Morphine
7%
Type 1 Diabetes Mellitus (T1DM)
6%
Diabetes
6%
Diabetic
6%
β-endorphin
6%
Immunoreactivity
6%
Topical Application
5%
Receptor-mediated
5%
Human Colon Cancer
5%
Preweaning
5%
Complementary DNA (cDNA)
5%
Rat Cerebellum
5%
Neuroscience
Growth Factor
72%
Naltrexone
50%
Enkephalin
41%
Opiate
35%
Endorphin
32%
Growth Factor Receptor
27%
Cell Proliferation
16%
DNA Synthesis
16%
δ -Opioid Receptor
15%
Neuroblastoma
14%
Experimental Autoimmune Encephalomyelitis
13%
Methadone
13%
Eicosanoid Receptor
13%
Opioid Antagonist
13%
Cerebellum
12%
Diabetes Mellitus
11%
Cornea
11%
Opioid Peptide
11%
Naloxone
9%
Ontogeny
8%
Multiple Sclerosis
7%
Corneal Epithelium
7%
Preproenkephalin
6%
Morphine
6%
Behavior (Neuroscience)
5%
Pharmacology, Toxicology and Pharmaceutical Science
Growth Factor
77%
Naltrexone
48%
Opiate
39%
Receptor
38%
Enkephalin
36%
Growth Factor Receptor
28%
Opiate Receptor
27%
Endorphin
21%
Diabetes Mellitus
15%
Neoplasm
15%
Malignant Neoplasm
14%
Pancreas Cancer
12%
Mouse
11%
Multiple Sclerosis
10%
Experimental Autoimmune Encephalomyelitis
9%
Opioid Antagonist
9%
Squamous Cell Carcinoma
9%
Wound Healing
7%
Nude Mouse
6%
Neuroblastoma
6%
Ovary Cancer
6%
Diseases
6%
Wound
5%
Naloxone
5%